How Much Did Spirosure Raise?
Funding & Key Investors

Spirosure, a California-based medical technology innovator, has successfully secured significant capital to advance its respiratory health diagnostic platform. The firm has reached a cumulative valuation milestone represented by $26.4M, bolstered by a recent strategic investment of $17.4M. This infusion of capital underscores the market confidence in the company's proprietary sensor technology and its potential to disrupt the management of chronic pulmonary conditions through non-invasive digital health solutions.

What is Spirosure?

Spirosure
ManufacturingMedical Devices & Equipment

Founded in 2011 and headquartered in Pleasanton, Spirosure operates at the intersection of consumer electronics and clinical diagnostics. The company specializes in the development of sophisticated measurement instruments designed to monitor respiratory diseases such as asthma, COPD, and chronic pulmonary hypertension. By leveraging a proprietary nexus of sensors and advanced algorithms, Spirosure provides cost-effective, non-invasive tools that empower patients and clinicians to manage chronic health issues with greater precision. The company's market position is defined by its commitment to preventative healthcare, effectively bridging the gap between traditional medical hardware and modern digital health ecosystems.

How much funding has Spirosure raised?

Spirosure has raised a total of $26.4M across 2 funding rounds:

2014

Series B

$9M

2016

Series C

$17.4M

Series B (2014): $9M, investors not publicly disclosed

Series C (2016): $17.4M, investors not publicly disclosed

Key Investors in Spirosure

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Spirosure?

With the successful closure of its latest financing round, Spirosure is positioned to accelerate the commercialization of its respiratory monitoring suite. The strategic roadmap likely involves scaling manufacturing capabilities, expanding clinical validation studies, and deepening the integration of its digital health tools into existing healthcare provider workflows. As the company transitions from a development-focused venture to a market-scaling enterprise, the focus will remain on enhancing the accuracy of its diagnostic algorithms and broadening its reach within the global respiratory care market. This capital deployment is critical for maintaining a competitive edge in the rapidly evolving landscape of remote patient monitoring and chronic disease management.

See full Spirosure company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingTextiles & ApparelRetailApparel & Accessories Retail
ManufacturingPet ProductsRetail
AppliancesManufacturing
ManufacturingTextiles & Apparel

Frequently Asked Questions Regarding Spirosure Financial Insights

What are the most recent funding rounds that Spirosure has completed, and what were the funding rounds?
Spirosure has recently completed 2 funding rounds: Series C on Jun 1, 2016, Series B on Oct 30, 2014.
What is the total amount of funding Spirosure has raised to date?
Spirosure has raised a total of $26.4M in funding to date.
How many funding rounds has Spirosure completed?
Spirosure has completed 2 funding rounds.
How much funding did Spirosure raise in its most recent funding round?
Spirosure raised $17.4M in its most recent funding round.
Which was the largest funding round in Spirosure's history?
The largest funding round in Spirosure's history was $17.4M.
See more information about Spirosure